Skip to Main Content

Paper Details

Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium.
J Thorac Oncol
3
2023
-IIIA, LCSS, Lung Cancer, NSCLC, Patients, Respiratory and cardiometabolic comorbidities, Stage I-III NSCLC, cardiometabolic and respiratory comorbidities, cardiometabolic comorbidities, cardiometabolic or respiratory comorbidities, lung cancer, non-small cell lung cancer, patients, respiratory and cardiometabolic comorbidities, respiratory comorbidities, stage I-IIIA NSCLC
Author NameAffiliation
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Brazil Life and Health Sciences Research Institute (ICVS), University of Minho
Wei XuThe Princess Margaret Cancer Centre and University Health Network, University of Toronto, Canada Dalla Lana School of Public Health
Rayjean J HungDalla Lana School of Public Health, University of Toronto, Canada Lunenfeld-Tanenbaum Research Institute
Geoffrey LiuThe Princess Margaret Cancer Centre and University Health Network, University of Toronto
  • 1 - 4

Datasets

Release 1.2